News from novocure A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

02 Dec, 2014, 13:00 GMT Novocure Announces FDA Approval of an IDE Supplement Allowing All Control Patients in its Phase III Trial in Newly Diagnosed GBM to Cross Over to Receive Tumor Treating Fields

Novocure announced today that the United States Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) supplement...


15 Nov, 2014, 15:17 GMT Novocure Announces the EF-14 Phase III Clinical Trial of Tumor Treating Fields in Patients with Newly Diagnosed Glioblastoma has been Terminated at the Interim Analysis due to Early Success

Novocure™, a commercial stage oncology company, announced today that Tumor Treating Fields (TTFields) delivered by the NovoTTF™-100A System in...


11 Nov, 2014, 13:00 GMT Novocure Announces the Presentation of New Data at the 19th Annual Society of Neuro-Oncology Meeting

Novocure™, a commercial stage oncology company, announced today that the pre-specified interim analysis of the pivotal phase III EF-14 study, a...


30 Oct, 2014, 12:00 GMT Novocure™ Enrolls First Patient in a Pilot Study of Tumor Treating Fields (TTFields) Together with Paclitaxel for the Treatment of Recurrent Ovarian Cancer

Novocure announced today that the first patient has been enrolled in the INNOVATE study, an open-label pilot clinical study of TTFields together with ...


29 Oct, 2014, 12:00 GMT Novocure™ Announces Publication of a NovoTTF™ Therapy Supplement in Seminars in Oncology Including Analyses of its U.S. Commercial Patient Registry Dataset (PRiDe)

Novocure, a commercial stage oncology company, announced today the publication of four articles on NovoTTF Therapy in a Seminars in Oncology...


25 Sep, 2014, 13:00 BST Novocure™ Announces Recurrent Glioblastoma Patient Registry Dataset (PRiDe) to be Presented at ESMO and EANO 2014

Novocure, a commercial stage oncology company, announced today that survival and efficacy data from its U.S. patient registry will be presented at...


04 Sep, 2014, 13:00 BST NovoTTF™-100A System Granted High Unmet Medical Need Designation by the Japanese Ministry of Health and Welfare

Novocure, a commercial stage oncology company, announced today that the Japanese Ministry of Health and Welfare (MHLW) has granted High Unmet Medical ...


21 Aug, 2014, 13:00 BST Novocure Announces the Submission of a Pre-Marketing Approval Application in Japan for the NovoTTF™-100A System to Treat Recurrent Glioblastoma

Novocure, a commercial stage oncology company, announced today that it has submitted the registration dossier for Pre-Market Approval (PMA) of the...


15 Jul, 2014, 09:00 BST Novocure Announces Commercial Launch of NovoTTF™ Therapy in Europe and Israel

Novocure, a commercial stage oncology company, announced today that 18 prominent neurosurgeons and neuro-oncologists at medical centers in Europe and ...


13 Jun, 2014, 13:00 BST Novocure Announces the Presentation of Subgroup Survival Data for Recurrent Glioblastoma Patients Treated with NovoTTF™ Therapy

Novocure, a commercial stage oncology company, announced today that subgroup survival data from its U.S. commercial patient registry will be...


19 May, 2014, 13:00 BST Novocure Announces the Publication of New Survival Data for Recurrent Glioblastoma Patients Treated with NovoTTF™ Therapy

Novocure, a commercial stage oncology company, announced today that an analysis of the efficacy and safety data from its U.S. patient registry will...


08 May, 2014, 15:00 BST Novocure "Tunes-In" During Brain Cancer Awareness Month This May to Support People Fighting Glioblastoma

For the second consecutive year, Novocure is sponsoring its Tune-In to GBM campaign, a public call to action to "Tune-In" to glioblastoma (GBM)...


03 Apr, 2014, 16:15 BST Novocure to Present New Pre-Clinical Data on NovoTTF™ Therapy at the American Association for Cancer Research Annual Meeting 2014

Novocure, a commercial stage oncology company, announced today that new, pre-clinical data demonstrating the anti-tumor effects of NovoTTF™ Therapy...


18 Feb, 2014, 14:01 GMT Novocure Announces First Commercial License of the NovoTAL™ (Transducer Array Layout) System

Novocure announced today that Harvard Medical Faculty Physicians at Beth Israel Deaconess Medical Center has licensed the NovoTAL (Transducer Array...


24 Jan, 2014, 14:00 GMT Novocure Enrolls First Patient in Pilot Clinical Trial of NovoTTF™ Therapy Plus Gemcitabine for First-line Treatment of Advanced Pancreatic Adenocarcinoma

Novocure announced today that the first patient has enrolled in the EF-20 Study, an open label, pilot clinical trial of NovoTTF Therapy plus...


06 Jan, 2014, 14:00 GMT Data Published in Pancreatology Demonstrates Activity of NovoTTF™ Therapy in Preclinical Models of Pancreatic Cancer, Alone and in Combination with Chemotherapy

Novocure™ announced today that the first evidence of activity of NovoTTF Therapy in pancreatic cancer tumor models was published online (December...


10 Dec, 2013, 16:23 GMT Centers for Medicare and Medicaid Services (CMS) Has Established Permanent Billing Codes for the NovoTTF-100A System™

Novocure announced today that the Centers for Medicare and Medicaid Services (CMS) has established new therapy-specific Healthcare Common Procedure...


21 Nov, 2013, 14:28 GMT Novocure Announces Launch of the inovitro™ Lab Research System

Today, Novocure announced the launch of the inovitro, a propriety plug-and-play laboratory research system that allows scientists to apply Tumor...


19 Nov, 2013, 15:31 GMT Novocure Enrolls First Patients in a Randomized Trial of NovoTTF™ Therapy for Patients with Brain Metastases from Non-Small Cell Lung Cancer

Novocure announced today that the first patients have enrolled in the EF-21 Study, a prospective randomized clinical study of NovoTTF™ Therapy for...


18 Nov, 2013, 14:00 GMT Novocure to Present Fifteen Abstracts Describing Latest Aspects of NovoTTF™ Therapy at the 4th Quadrennial Meeting of the World Federation of Neuro-Oncology (WFNO)

Novocure announced today that 15 preclinical and clinical abstracts describing the latest aspects of NovoTTF™ Therapy will be presented at the 4th...


05 Nov, 2013, 14:00 GMT Novocure Announces FDA Approval of the NovoTAL™ (Transducer Array Layout) System

Novocure announced today that the United States Food and Drug Administration (FDA) has approved the NovoTAL (Transducer Array Layout) System through...


04 Sep, 2013, 12:00 BST Results of First Multi-Center Trial of NovoTTF™ Therapy in Combination with Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) Published in Lung Cancer

Results of the first clinical trial to study treatment with tumor treating field therapy (NovoTTF Therapy) in combination with chemotherapy for...


31 Jul, 2013, 17:18 BST Novocure Treats First Recurrent Glioblastoma Patient in Japan with NovoTTF™ Therapy

Novocure today announced that Dr. Tatsunori Okamaura, MD, Ph.D., of the Kashiwaba Neurosurgical Hospital in Sapporo, Japan has treated the first...


10 Apr, 2013, 14:00 BST Novocure Presents Preclinical Data at the American Association for Cancer Research (AACR)

Novocure announced today that new data from preclinical testing of NovoTTF Therapy in non-small cell lung carcinoma (NSCLC), ovarian and pancreatic...


09 Aug, 2012, 15:30 BST Galien Foundation selects NovoTTF™-100A System as a finalist for the Prix Galien USA Award

The Galien Foundation announced today that it has selected the NovoTTF™-100A System as a finalist for the prestigious Prix Galien USA Award in Best...